MRI quantitative susceptibility mapping of the substantia nigra as an early biomarker for Lewy body disease

Neurodegeneration of the substantia nigra in Lewy body disease is associated with iron deposition, which increases the magnetic susceptibility of the substantia nigra on MRI. Our objective was to measure iron deposition in the substantia nigra in patients with probable dementia with Lewy bodies (pDLB) and patients who are at risk for pDLB by quantitative susceptibility mapping (QSM).

[1]  Alan J. Thomas,et al.  Research criteria for the diagnosis of prodromal dementia with Lewy bodies , 2020, Neurology.

[2]  M. Cosottini,et al.  Quantitative susceptibility mapping in atypical Parkinsonisms , 2019, NeuroImage: Clinical.

[3]  David T. Jones,et al.  Comparison of the Short Test of Mental Status and the Montreal Cognitive Assessment Across the Cognitive Spectrum. , 2019, Mayo Clinic proceedings.

[4]  R. Zivadinov,et al.  Ventral posterior substantia nigra iron increases over 3 years in Parkinson's disease , 2019, Movement disorders : official journal of the Movement Disorder Society.

[5]  E. Haacke,et al.  Regional High Iron in the Substantia Nigra Differentiates Parkinson’s Disease Patients From Healthy Controls , 2019, Front. Aging Neurosci..

[6]  Qiqi Chen,et al.  Iron deposition in Parkinson’s disease by quantitative susceptibility mapping , 2019, BMC Neuroscience.

[7]  G. Wenning,et al.  Iron in Neurodegeneration – Cause or Consequence? , 2019, Front. Neurosci..

[8]  David A. Edmondson,et al.  Impairment of Motor Function Correlates with Neurometabolite and Brain Iron Alterations in Parkinson’s Disease , 2019, Cells.

[9]  R. Mailman,et al.  Susceptibility MRI captures nigral pathology in patients with parkinsonian syndromes , 2018, Movement disorders : official journal of the Movement Disorder Society.

[10]  Robert Turner,et al.  Quantitative Susceptibility Mapping of Amyloid-β Aggregates in Alzheimer's Disease with 7T MR. , 2018, Journal of Alzheimer's disease : JAD.

[11]  Shih-Jung Cheng,et al.  Risk Factors for the Progression of Mild Cognitive Impairment in Different Types of Neurodegenerative Disorders , 2018, Behavioural neurology.

[12]  D. Auer,et al.  Parkinson's disease related signal change in the nigrosomes 1–5 and the substantia nigra using T2* weighted 7T MRI , 2018, NeuroImage: Clinical.

[13]  V. Uversky,et al.  Alpha-synuclein inhibits Snx3–retromer-mediated retrograde recycling of iron transporters in S. cerevisiae and C. elegans models of Parkinson’s disease , 2018, Human molecular genetics.

[14]  Wei Zhou,et al.  Quantifying iron deposition within the substantia nigra of Parkinson's disease by quantitative susceptibility mapping , 2018, Journal of the Neurological Sciences.

[15]  T. Uchihara,et al.  Reader response: Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB consortium , 2018, Neurology.

[16]  L. Wahlund,et al.  MRI of the Swallow Tail Sign: A Useful Marker in the Diagnosis of Lewy Body Dementia? , 2017, American Journal of Neuroradiology.

[17]  Clifford R. Jack,et al.  THE MAYO CLINIC ADULT LIFESPAN TEMPLATE: BETTER QUANTIFICATION ACROSS THE LIFESPAN , 2017, Alzheimer's & Dementia.

[18]  C. Jack,et al.  THE MAYO CLINIC ADULT LIFE SPAN TEMPLATE: BETTER QUANTIFICATION ACROSS THE LIFE SPAN , 2017, Alzheimer's & Dementia.

[19]  S. Aoki,et al.  Diagnostic imaging of dementia with Lewy bodies by susceptibility-weighted imaging of nigrosomes versus striatal dopamine transporter single-photon emission computed tomography: a retrospective observational study , 2017, Neuroradiology.

[20]  Daniel E. Huddleston,et al.  Parkinson's disease–related increase of T2* ‐weighted hypointensity in substantia nigra pars compacta , 2017, Movement disorders : official journal of the Movement Disorder Society.

[21]  R. Barker,et al.  Motor associations of iron accumulation in deep grey matter nuclei in Parkinson's disease: a cross‐sectional study of iron‐related magnetic resonance imaging susceptibility , 2017, European journal of neurology.

[22]  Siobhan Ewert,et al.  Toward defining deep brain stimulation targets in MNI space: A subcortical atlas based on multimodal MRI, histology and structural connectivity , 2016, NeuroImage.

[23]  Ferdinand Schweser,et al.  Quantitative Susceptibility Mapping in Parkinson's Disease , 2016, PloS one.

[24]  E Mark Haacke,et al.  Quantifying brain iron deposition in patients with Parkinson's disease using quantitative susceptibility mapping, R2 and R2. , 2015, Magnetic resonance imaging.

[25]  Carlos Ortiz-de-Solorzano,et al.  Automated Neuromelanin Imaging as a Diagnostic Biomarker for Parkinson's Disease , 2015, Movement disorders : official journal of the Movement Disorder Society.

[26]  J. Armspach,et al.  Neural correlates of visual hallucinations in dementia with Lewy bodies , 2015, Alzheimer's Research & Therapy.

[27]  Clifford R. Jack,et al.  Pattern of brain atrophy rates in autopsy-confirmed dementia with Lewy bodies , 2015, Neurobiology of Aging.

[28]  Shu-Hua Huang,et al.  Cortical Metabolic and Nigrostriatal Abnormalities Associated With Clinical Stage-Specific Dementia With Lewy Bodies , 2015, Clinical nuclear medicine.

[29]  O. Kraft,et al.  Transcranial sonography and (123)I-FP-CIT single photon emission computed tomography in movement disorders. , 2014, Ultrasound in medicine & biology.

[30]  Yi Wang,et al.  Quantitative susceptibility mapping (QSM): Decoding MRI data for a tissue magnetic biomarker , 2014, Magnetic resonance in medicine.

[31]  B. Boeve,et al.  Incidence of dementia with Lewy bodies and Parkinson disease dementia. , 2013, JAMA neurology.

[32]  Ferdinand Schweser,et al.  Quantitative susceptibility mapping (QSM) as a means to measure brain iron? A post mortem validation study , 2012, NeuroImage.

[33]  Chunlei Liu,et al.  Whole brain susceptibility mapping using compressed sensing , 2012, Magnetic resonance in medicine.

[34]  Ronald C Petersen,et al.  Validation of the Mayo Sleep Questionnaire to screen for REM sleep behavior disorder in an aging and dementia cohort. , 2011, Sleep medicine.

[35]  Bing Wu,et al.  Quantitative susceptibility mapping of human brain reflects spatial variation in tissue composition , 2011, NeuroImage.

[36]  J. Molinuevo,et al.  Decreased striatal dopamine transporter uptake and substantia nigra hyperechogenicity as risk markers of synucleinopathy in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study , 2010, The Lancet Neurology.

[37]  E G Tangalos,et al.  Prevalence of mild cognitive impairment is higher in men , 2010, Neurology.

[38]  B. Boeve.  REM sleep behavior disorder , 2010, Annals of the New York Academy of Sciences.

[39]  Bharathi,et al.  Molecular Understanding of Copper and Iron Interaction with α-Synuclein by Fluorescence Analysis , 2008, Journal of Molecular Neuroscience.

[40]  C. Ross,et al.  Single Particle Characterization of Iron-induced Pore-forming α-Synuclein Oligomers* , 2008, Journal of Biological Chemistry.

[41]  V. Pankratz,et al.  The Mayo Clinic Study of Aging: Design and Sampling, Participation, Baseline Measures and Sample Characteristics , 2008, Neuroepidemiology.

[42]  Brian B. Avants,et al.  Symmetric diffeomorphic image registration with cross-correlation: Evaluating automated labeling of elderly and neurodegenerative brain , 2008, Medical Image Anal..

[43]  Karl J. Friston,et al.  Unified segmentation , 2005, NeuroImage.

[44]  R. Petersen.  Mild cognitive impairment as a diagnostic entity , 2004, Journal of internal medicine.

[45]  Yimei Zhu,et al.  Fast phase unwrapping algorithm for interferometric applications. , 2003, Optics letters.

[46]  H. Braak,et al.  Staging of brain pathology related to sporadic Parkinson’s disease , 2003, Neurobiology of Aging.

[47]  D. Allsop,et al.  alpha-Synuclein implicated in Parkinson's disease catalyses the formation of hydrogen peroxide in vitro. , 2001, Free radical biology & medicine.

[48]  E. Tangalos,et al.  The short test of mental status. Correlations with standardized psychometric testing. , 1991, Archives of neurology.

[49]  W. Kraus,et al.  Original Papers , 1924, The Journal of neurology and psychopathology.

[50]  E. Haacke,et al.  Quantitative susceptibility mapping: current status and future directions. , 2015, Magnetic resonance imaging.

[51]  C. Marsden,et al.  Recent Developments in Parkinson's Disease , 1986 .

[52]  Diane C. Tsai.  Recent Developments in Parkinson's Disease , 1986, The Yale Journal of Biology and Medicine.